IONP–GA/PAA significantly killed glioblastoma (U87MG and U373MG), high-risk MYCN amplified neuroblastoma (IMR32), fibrosarcoma (HT1080), and HT22 neuronal (non-tumorigenic) cell lines (Figure 3A). The gene discussed is MYCN; the disease is neuroblastoma.